(Reuters) -Singapore Airlines said on Thursday it expects competition to intensify in the coming months as carriers scramble to take advantage of strong overseas travel demand that helped the city-sta[...]
Read moreUncategorized
Marketmind: ECB to follow Fed hike, Meta surges
A look at the day ahead in U.S. and global markets from Mike Dolan With markets still betting Wednesday’s interest rate hike from the Federal Reserve was the last in the cycle, the European Cent[...]
Read moreHedge funds rush to buy China stocks on economy stimulus prospects – Goldman
By Summer Zhen HONG KONG (Reuters) – Global hedge funds snapped up Chinese equities following the politburo meeting this week, buying on Tuesday at their fastest pace since October 2022, Goldman[...]
Read moreMicrosoft in EU antitrust crosshairs over Teams, Office tying
By Foo Yun Chee and Sudip Kar-Gupta BRUSSELS (Reuters) -Microsoft on Thursday found itself the target of an EU antitrust investigation over the tying of its chat and video app Teams with its Office pr[...]
Read moreKeppel’s H1 profit soars seven-fold on one-off gain from O&M unit sale
(Reuters) -Singapore’s Keppel Corp on Thursday reported a more than seven-fold jump in its first-half profit boosted by a one-off gain from the sale of its offshore and marine (O&M) unit and[...]
Read moreNestle says price rises will moderate in rest of 2023
LONDON (Reuters) – Nestle will raise prices at a more moderate rate in the remainder of 2023, its CEO said on Thursday, as the company hit back at criticism that food manufacturers are charging[...]
Read moreNestle sales outlook brightens after strong first half
By Richa Naidu LONDON (Reuters) -Nestle improved its full-year organic sales outlook and reported better-than-expected first-half organic sales, as the world’s biggest packaged food company agai[...]
Read moreBNP Paribas facing potential fine as it resolves U.S. messaging probe
PARIS (Reuters) – BNP Paribas is set to resolve a U.S. probe into employees’ use of unapproved messaging platforms, its mid-year earnings report showed on Thursday, which could see the Fre[...]
Read moreJapan’s Takeda beats Q1 profit estimates on mainstay drugs, dengue vaccine
TOKYO (Reuters) -Japan’s Takeda Pharmaceutical posted first-quarter profit that beat analysts’ estimates, citing solid sales of mainstay drugs and the launch of new products including its[...]
Read more